The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol “ABBV”.
According to AbbVie's latest financial reports the company's current EPS (TTM) is $5.86. In 2022 the company made an earnings per share (EPS) of $10.59 an increase over its 2021 EPS that were of $10.32.